COF-based artificial probiotic for modulation of gut microbiota and immune microenvironment in inflammatory bowel disease-Reference-Cited by-同舟云学术

COF-based artificial probiotic for modulation of gut microbiota and immune microenvironment in inflammatory bowel disease

Published:2023 Issue:6 Volume:14 Page:1598-1605
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Deng Qingqing¹²,Zhang Lu¹,Liu Xuemeng¹²,Kang Lihua³,Yi Jiadai¹²,Ren Jinsong¹²^ORCID,Qu Xiaogang¹²^ORCID

Affiliation:

1. State Key Laboratory of Rare Earth Resources Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China

2. University of Science and Technology of China, Hefei, Anhui 230029, China

3. Cancer Center, First Affiliated Hospital, Jilin University, Changchun, Jilin, 130061, P. R China

Abstract

COF-based artificial probiotics, functioning like natural probiotics, markedly relieve IBD by modulating the gut microbiota, suppressing intestinal inflammation, protecting the intestinal epithelial cells, and regulating immunity.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/SC/D2SC04984H

Reference61 articles.

1. The gut microbiota shapes intestinal immune responses during health and disease

2. Dynamics of the human gut microbiome in inflammatory bowel disease